Bio-Rad Launches ddSEQ Single-Cell 3′ RNA-Seq Kit for Single-Cell Gene Expression
June 19, 2024 – Drug Discovery, Other, Pharmaceutical – Bio-Rad Laboratories, molecular biology, oncology, single-cell gene expression
ddSEQ single-cell 3′ RNA-Seq kit and Omnition v1.1 analysis software enable high-quality and affordable single-cell transcription and gene expression to support molecular biology, oncology and drug discovery research
19 June 2024 — California, US — Bio-Rad Laboratories, a global leader in life sciences research and clinical diagnostics products, today announced the launch of the ddSEQ Single-Cell 3′ RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.
Designed to be run on Bio-Rad’s droplet-based single-cell isolation system, the ddSEQ Cell Isolator, the ddSEQ Single-Cell 3′ RNA-Seq Kit delivers high-quality single-cell 3′ RNA-Seq libraries in a fast, efficient and affordable workflow, allowing researchers to easily conduct single-cell gene expression and regulation analyses. The subsequent QC, analysis and reporting of data generated from the ddSEQ Single-Cell 3′ RNA-Seq Kit is enabled by the accompanying Omnition v1.1 Analysis Software, a robust pipeline analysis tool. These valuable insights into single-cell transcription and gene expression support a broad range of research fields such as oncology, immunology, neurology and stem cell biology.
“The new ddSEQ Single-Cell 3′ RNA-Seq Kit expands our NGS library preparation portfolio and is a further reflection of our commitment to provide researchers with innovative technologies to support molecular biology, oncology and drug discovery research,” said Stephen Kulisch, vice president of Marketing for Bio-Rad’s Digital Biology Group. “Used with our ddSEQ Cell Isolator, the new kit and Omnition v1.1 Analysis Software presents a more cost-effective solution for single-cell transcription and gene expression studies, facilitating seamless integration into a broad spectrum of research applications and empowering research teams to undertake more experiments within the same budget.”
To learn more about the ddSEQ Single-Cell 3′ RNA-Seq Kit, visit www.bio-rad.com/ddSEQ3scRNA-SeqKit
About Bio-Rad
Bio-Rad Laboratories is a leader in developing, manufacturing and marketing a broad range of products for the life sciences research and clinical diagnostics markets. Based in Hercules, California, US, Bio-Rad operates a global network of research, development, manufacturing and sales operations with approximately 8,000 employees and $2.7bn in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
